Llewellyn King on the unfolding drama of FDA’s Dec 20 Ampligen hearing

1 Star2 Stars3 Stars4 Stars5 Stars (7 votes, average: 5.00 out of 5)
Loading...

After much suffering, the biblical character Lazarus was raised from the dead. Will the FDA look favorably on the ‘Lazarus’ drug Ampligen after its ME/CFS patient hearing on Thursday, Dec 20?

The live online hearing will feature public testimony from ME/CFS patients who believe use of this potent experimental drug has helped them. For a concise description of the stakes & uncertainties involved, see “FDA to rule on ‘Lazarus’ drug,” published Dec 15 by ME/CFS Alert co-host Llewellyn King at StamfordAdvocate.com.